Yablonka Uri Insider Trades

Insider Trading History

Track insider trading activity for Yablonka Uri. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP & Chief Business Officer
Holding Value $199k 218,464 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99k 150,000 shares
$0.66
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP & Chief Business Officer
Holding Value $116k 126,969 shares
Last Trade
Mar 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$539k 109,426 shares
$4.93
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $12.1k 13,333 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$658k 13,333 shares
$49.35
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $12.1k 13,333 shares
Last Trade
Dec 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$684k 13,333 shares
$51.30
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP & Chief Business Officer
Holding Value $16k 17,543 shares
Last Trade
Jun 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 10,000 shares
$149.70
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP And Chief Business Officer
Holding Value $12.1k 13,333 shares
Last Trade
Dec 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$777k 13,333 shares
$58.28
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP And Chief Business Officer
Holding Value $12.1k 13,333 shares
Last Trade
Nov 30, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$622k 13,333 shares
$46.65
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP And Chief Business Officer
Holding Value $12.1k 13,333 shares
Last Trade
Nov 10, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$818k 13,333 shares
$61.35
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP & Chief Business Officer
Holding Value $6.86k 7,543 shares
Last Trade
Aug 23, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$123k 2,000 shares
$61.35
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
EVP & Chief Business Officer
Holding Value $5.04k 5,543 shares
Last Trade
Jul 13, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$375k 5,543 shares
$67.65
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Operating Officer
Holding Value $12.1k 13,333 shares
Last Trade
Jun 22, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$488k 13,333 shares
$36.60
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Operating Officer
Holding Value $12.1k 13,333 shares
Last Trade
Aug 27, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$580k 13,333 shares
$43.50
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Operating Officer
Holding Value $182k 200,000 shares
Last Trade
Aug 15, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3M 200,000 shares
$66.34
$0.91
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Chief Operating Officer
Holding Value $455k 500,000 shares
Last Trade
Jun 06, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6M 500,000 shares
$65.22
$0.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up